| pubmed-article:11098980 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C0021289 | lld:lifeskim |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C0021270 | lld:lifeskim |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C0028128 | lld:lifeskim |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C0015357 | lld:lifeskim |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C1135361 | lld:lifeskim |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C0686904 | lld:lifeskim |
| pubmed-article:11098980 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:11098980 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:11098980 | pubmed:dateCreated | 2000-12-11 | lld:pubmed |
| pubmed-article:11098980 | pubmed:abstractText | We previously reported improved oxygenation, but no change, in rates of extracorporeal membrane oxygenation (ECMO) use or death among infants with persistent pulmonary hypertension of the newborn who received inhaled nitric oxide (NO) with conventional ventilation, irrespective of lung disease. The goal of our study was to determine whether treatment with inhaled NO improves oxygenation and clinical outcomes in infants with persistent pulmonary hypertension of the newborn and associated lung disease who are ventilated with high-frequency oscillatory ventilation (HFOV). | lld:pubmed |
| pubmed-article:11098980 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11098980 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11098980 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11098980 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11098980 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11098980 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11098980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11098980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11098980 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11098980 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11098980 | pubmed:issn | 0090-3493 | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:ThompsonJ EJE | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:AllredE NEN | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:KaneJ WJW | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:StarkA RAR | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:WesselD LDL | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:KourembanasSS | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:Van MarterL... | lld:pubmed |
| pubmed-article:11098980 | pubmed:author | pubmed-author:ChristouHH | lld:pubmed |
| pubmed-article:11098980 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11098980 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:11098980 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11098980 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11098980 | pubmed:pagination | 3722-7 | lld:pubmed |
| pubmed-article:11098980 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:meshHeading | pubmed-meshheading:11098980... | lld:pubmed |
| pubmed-article:11098980 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11098980 | pubmed:articleTitle | Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. | lld:pubmed |
| pubmed-article:11098980 | pubmed:affiliation | Department of Medicine, Children's Hospital, Boston, MA 02115, USA. | lld:pubmed |
| pubmed-article:11098980 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11098980 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11098980 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11098980 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11098980 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11098980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11098980 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11098980 | lld:pubmed |
